This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. Its unique cyclobutyl structure makes it a valuable intermediate in the creation of molecules targeting various therapeutic areas, such as central nervous system disorders and metabolic diseases. It is often employed in medicinal chemistry to modify the pharmacokinetic properties of lead compounds, enhancing their bioavailability or stability. Additionally, it serves as a building block in the design of peptidomimetics, which mimic the structure and function of peptides for drug discovery purposes. Its hydrochloride form ensures better solubility and handling in experimental settings.